Drugs / SPIONs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04316091 | Sep 2020 → Aug 2021 | bone osteosarcoma | Second Affiliated Hospital, School of Medicine, Zhejiang University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPIONs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04316091 ↗ |
| Known as | Superparamagnetic Iron Oxide Nanoparticles | “Superparamagnetic Iron Oxide Nanoparticles (SPIONs)/Spinning Magnetic Field (SMF) and neoadjuvant chemotherapy may increase the cancer cell killing” NCT04316091 ↗ |
| Route | Other | “intratumoral injection of SPIONs” NCT04316091 ↗ |